C-Rad
44,2 SEK -2,86%Vær den første som følger denne virksomhed
C-Rad is active in medical technology. The company conducts the development, manufacturing, and sales of products and solutions in advanced radiation therapy. The business is mainly aimed at clinics that offer radiation treatment, where the company in addition to its core business offers associated installation services and support. The customers are located on a global level and the head office is located in Uppsala.
Omsætning
-
EBIT %
-
P/E
32,5
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
CRAD B
Daglig lav / høj pris
44,05 / 45,3
SEK
Markedsværdi
1,49 mia. SEK
Aktieomsætning
1,66 mio. SEK
Volumen
37 t
Finanskalender
Delårsrapport
23.10.2024
Årsrapport
07.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Svea Bank AB | 11,9 % | 11,9 % |
Linc AB | 7,6 % | 11,9 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
C-RAD AB has decided to repurchase own shares
Reminder: C-RAD Web Presentation Interim Report Q2 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools